Barbara Burtness, MD highlights key news in head and neck cancer from ESMO 2025, including CAMORAL, ASPEN-03 & -04, OrigAMI-4 & -05 results.

Future research should focus on implementation studies and effectiveness in clinical settings and explore the applicability of TG-iConquerFear across different cancer types,” study researchers noted.

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

An artificial intelligence-based imaging analysis could serve as an aid in surgical planning for patients with kidney tumors.

A method to address discrepancies between predicted biological age and actual chronological age has been validated as a biomarker in predicting OS.

After nephron-sparing treatment for RCC, patients with local recurrence had a higher mortality risk than patients without recurrence.

Current risk stratification models perform well in assessing recurrence risk in patients with non-clear cell renal cell carcinoma, researchers report.

An AI-based model for analyzing images appeared better able to predict ccRCC from CT-based images than a tumor size-based model was.